Slate Path Capital Portfolio holdings
Slate Path Capital runs hedge funds that go long and short on stocks around the world, with sizeable positions in other assets too. The firm was established in 2012 and is owned by David Greenspan and JADES GP, a company in which Greenspan is the principal owner. Its stock picking rests on company research, and it aims for long-term growth adjusted for risk. Its two main funds use significant leverage and concentrated positions, and the firm can also trade digital assets such as Bitcoin and Ethereum. One group of its funds avoids long positions in fossil fuel assets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$71.4M |
| 2 |
TripAdvisor
TRIP
|
+$37.9M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$27.3M |
| 4 |
PayPal
PYPL
|
+$22.4M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zillow
Z
|
+$56M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$21.3M |
| 3 |
Oneok
OKE
|
+$19.9M |
| 4 |
Williams Companies
WMB
|
+$17M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.64% |
| 2 | Financials | 16.02% |
| 3 | Healthcare | 13.95% |
| 4 | Communication Services | 13.61% |
| 5 | Consumer Discretionary | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $329M | 25.53% |
+1,600,000
| New | +$312M |
2016 Q1
0 quarters
|
|
|
2
VanEck Gold Miners ETF
GDX
$25.3B
| $207M | 16.11% |
10,390,000
+4,150,000
| +67% | +$71.4M |
2015 Q3
2 quarters
|
|
|
3
PayPal
PYPL
$49.2B
| $206M | 16.02% |
5,345,000
+620,000
| +13% | +$22.4M |
2015 Q3
2 quarters
|
|
4
Charter Communications
CHTR
$15.8B
| $153M | 11.87% |
755,000
+65,000
| +9% | +$11.7M |
2013 Q2
11 quarters
|
|
|
5
TripAdvisor
TRIP
$853M
| $105M | 8.13% |
1,575,000
+572,727
| +57% | +$37.9M |
2015 Q4
1 quarter
|
|
6
Insulet
PODD
$10.6B
| $90.2M | 7% |
2,720,000
| – | – |
2015 Q1
4 quarters
|
|
|
ANDV
7
DELISTED
Andeavor
ANDV
| $85.6M | 6.64% |
995,000
| – | – |
2014 Q3
6 quarters
|
|
|
8
Alnylam Pharmaceuticals
ALNY
$22.1B
| $71.2M | 5.53% |
1,135,000
+410,000
| +57% | +$27.3M |
2013 Q2
11 quarters
|
|
|
TWC
9
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $22.5M | 1.75% |
110,000
-75,000
| -41% | -$14.2M |
2015 Q3
2 quarters
|
|
|
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $18.2M | 1.41% |
+430,000
| New | +$21.9M |
2016 Q1
0 quarters
|
|
11
Kinder Morgan
KMI
$71.1B
| – | – |
-1,030,000
| Closed | -$15.4M | – |
|
|
12
Oneok
OKE
$56.6B
| – | – |
-805,000
| Closed | -$19.9M | – |
|
|
13
Williams Companies
WMB
$86.4B
| – | – |
-660,000
| Closed | -$17M | – |
|
|
14
Zillow
Z
$6.72B
| – | – |
-2,385,000
| Closed | -$56M | – |
|
|
MDCO
15
DELISTED
Medicines Co
MDCO
| – | – |
-570,000
| Closed | -$21.3M | – |
|
|
CPGX
16
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
| – | – |
-805,000
| Closed | -$16.1M | – |
|
Similar funds
Slate Path Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Slate Path Capital held 16 positions worth $1.29B, up 39% from $924M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Slate Path Capital's Q1 2016 filing shows 2 new, 5 increased, 1 reduced and 6 closed positions. Its largest new stake was IVERIC bio, Inc. Common Stock: 430,000 shares worth $18.2M. The largest sale was Zillow, an estimated $56M.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 9.3% a quarter earlier, followed by Financials and Healthcare.
- Slate Path Capital's largest Q1 2016 buy was IVERIC bio, Inc. Common Stock: 430,000 shares worth $18.2M.
- Slate Path Capital added most to VanEck Gold Miners ETF in Q1 2016, an estimated $71.4M increase.
- Slate Path Capital's biggest Q1 2016 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $14.2M.
- Slate Path Capital fully exited Zillow in Q1 2016, selling an estimated $56M.
- Slate Path Capital's ten largest holdings make up 100% of its $1.29B portfolio in Q1 2016.
- Slate Path Capital opened 2 new positions and closed 6 in Q1 2016.
- Slate Path Capital's portfolio value rose 39% quarter-over-quarter to $1.29B.
Based on Slate Path Capital's 13F filing for Q1 2016, filed 16 May 2016.